estriol has been researched along with Carcinoma in Situ in 1 studies
hormonin: estrogen replacement; each tablet contains 600 ug micronized 17beta-estradiol, 270 ug estriol and 1.4 mg estrone
chlorapatite : A phosphate mineral with the formula Ca5(PO4)3Cl.
Carcinoma in Situ: A lesion with cytological characteristics associated with invasive carcinoma but the tumor cells are confined to the epithelium of origin, without invasion of the basement membrane.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Turan, VK | 1 |
| Sanchez, RI | 1 |
| Li, JJ | 1 |
| Li, SA | 1 |
| Reuhl, KR | 1 |
| Thomas, PE | 1 |
| Conney, AH | 1 |
| Gallo, MA | 1 |
| Kauffman, FC | 1 |
| Mesia-Vela, S | 1 |
1 other study available for estriol and Carcinoma in Situ
| Article | Year |
|---|---|
The effects of steroidal estrogens in ACI rat mammary carcinogenesis: 17beta-estradiol, 2-hydroxyestradiol, 4-hydroxyestradiol, 16alpha-hydroxyestradiol, and 4-hydroxyestrone.
Topics: Animals; Carcinoma in Situ; Carcinoma, Ductal, Breast; Dose-Response Relationship, Drug; Drug Implan | 2004 |